Stock Market News for August 27, 2026

AI, infrastructure and transport innovation

Einride (ENRD) launched Flip AI, putting autonomous agents to work on fleet optimization — a practical step toward software‑driven efficiency in electric logistics.

ChronoScale (CHRN) announced an AI infrastructure partnership with Microsoft to deploy 50 MW of compute in North America, signaling more capacity for large‑model training and inference.

AZIO AI (AZIO) expanded its sales pipeline to roughly $307M for NVIDIA HGX systems and is developing a South Texas project, reflecting sustained enterprise demand for on‑site GPU capacity.

T1 (TE) secured approval for the Giga Arctic data‑center, adding hyperscale supply in a jurisdiction favorable to heavy AI workloads.

Enterprise software, security and infrastructure results

Workday (WDAY) released fiscal Q2 results (report), a key read on SaaS subscription trends and enterprise IT budgets.

Marvell Technology (MRVL) reported fiscal Q2 results (release), useful for gauging demand across data‑center switching and connectivity markets.

SentinelOne (S) announced second‑quarter fiscal 2027 financial results (details), a checkpoint on enterprise security spending and margin trajectory.

Rubrik (RBRK) posted Q2 fiscal 2027 results (report), and added governance items: it appointed Rakefet Russak‑Aminoach to the board and will present at Goldman Sachs’ Communacopia + Technology Conference, moves that can broaden guidance and investor access during a re‑rating window.

Elastic (ESTC) reported first quarter fiscal 2027 results (release), an indicator for search and observability platform consumption.

Biotech wins, regulatory cadence and trial catalysts

Moderna (MRNA) received U.S. FDA approval for its updated 2026‑2027 COVID‑19 vaccines, a commercial and revenue catalyst ahead of the respiratory‑vaccine season.

MBX Biosciences (MBX) dosed the first patient in its pivotal Phase 3 oPTimize trial of once‑weekly canvuparatide for hypoparathyroidism (release), a clear clinical milestone to watch for topline timing.

CytomX Therapeutics (CTMX) won FDA Fast Track for varsetatug masetecan in relapsed metastatic colorectal cancer, improving the drug’s regulatory runway.

Adicet Bio (ACET) announced FDA clearance of its IND for ADI‑212, enabling first‑in‑human study plans that investors treat as an early inflection point.

Kazia Therapeutics (KZIA) reported a 100% clinical benefit rate in an initial six‑patient cohort and filed a proposed public offering, a financing step that could accelerate development but may affect share count.

Retail earnings and consumer momentum

Dollar Tree (DLTR) delivered a strong second quarter, reinforcing resilience in value retail spending.

Dollar General (DG) reported results showing margin pressure but steady demand among price‑conscious shoppers (details), a read‑through for low‑price discretionary names.

Ulta Beauty (ULTA) announced Q2 results and raised guidance, a bullish signal for beauty spend heading into the back half.

Gap Inc. (GAP) reported second quarter fiscal 2026 results; investors will parse inventory and margin commentary for signs of pricing power.

Newegg (NEGG) released Q2 results, a timely read on e‑commerce fulfillment and consumer electronics trends that can inform marketplace peers.

Energy, semiconductors and industrial moves

Canadian Solar (CSIQ) posted Q2 results (report), providing a snapshot of module supply and utility‑scale demand amid project timelines.

Eos Energy Enterprises (EOSE) moved to consolidate battery manufacturing at Thorn Hill, a capacity and cost action aimed at improving margins for grid‑scale storage.

Diodes (DIOD) completed the acquisition of ElevATE Semiconductor, expanding its footprint in test equipment and power segments.

ARRAY Technologies (ARRY) will participate in investor conferences, a chance to update investors on utility‑scale solar deployment and backlog visibility.

Fintech and crypto

BitGo (BTGO) agreed to acquire NYDIG’s institutional trading business, expanding its derivatives and financing capabilities in the institutional crypto market (deal details). For investors, the move signals consolidation among crypto custody and trading providers and could reshape institutional access to derivatives liquidity.

FinVolution Group (FINV) reported second quarter 2026 unaudited financial results (release), offering a window into credit demand and non‑bank lending dynamics in China — a useful data point for emerging‑market credit risk and fintech growth narratives.

Corporate actions, governance and notable legal notes

Natuzzi (NTZ) received a delisting notice from the NYSE, a material governance and liquidity event for shareholders to monitor.

Live Ventures (LIVE) had the dismissal of all SEC claims, removing a major legal overhang and clearing a path for operational focus.

In corporate finance moves, Advasa Holdings (ADBT) completed a $940 million direct listing, a sizable capital markets event that may set valuation and liquidity expectations for similar listings.

Healthy Choice Wellness Corp. (HCWC) announced a 1‑for‑35 reverse stock split, a shareholder‑level move that can affect float and compliance status for small‑cap holders.